Phase 0- Pilot Study of Pembrolizumab on Immune Cells in Patient With Refractory Acute Myeloid Leukemia
Clinical trial NCT03291353 · WITHDRAWN
Trial details
- NCT number
- NCT03291353
- Sponsor
- Michael Boyiadzis
- Status
- WITHDRAWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-17
- Primary completion
- 2019-08-19
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.